| Catalog No. | HF862996 |
|---|
| Species reactivity | Human |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Isotype | Recombinant human FGF19 analogs. |
|---|
| Expression system | Mammalian Cells |
|---|
| Target | FGF19, Fibroblast growth factor 19, FGF-19 |
|---|
| Concentration | 1mg/ml |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Purified by nickel column chromatography. |
|---|
| Accession | O95750 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -2486°C. |
|---|
| Alternate Names | NGM282 |
|---|
| Background | Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH). |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
